AAAAAA

   
Results: 1-12 |
Results: 12
High-dose interferon alfa-2b does mot diminish antibody response to GM2 vaccination in patients with resected melanoma: Results of the multicenter Eastern Cooperative Oncology Group phase II trial E2696
Authors: Kirkwood, JM Ibrahim, J Lowson, DH Aikins, MB Agarwala, SS Collins, K Mascari, R Morrissey, DM Chapman, PB
Citation: Jm. Kirkwood et al., High-dose interferon alfa-2b does mot diminish antibody response to GM2 vaccination in patients with resected melanoma: Results of the multicenter Eastern Cooperative Oncology Group phase II trial E2696, J CL ONCOL, 19(5), 2001, pp. 1430-1436
Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin+QS21 vaccine: A dose-response study
Authors: Chapman, PB Morrissey, DM Panageas, KS Hamilton, WB Zhan, C Destro, AN Williams, L Israel, RJ Livingston, PO
Citation: Pb. Chapman et al., Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin+QS21 vaccine: A dose-response study, CLIN CANC R, 6(3), 2000, pp. 874-879
Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine:A trial comparing doses of G(D2)-keyhole limpet hemocyanin
Authors: Chapman, PB Morrisey, D Panageas, KS Williams, L Lewis, JJ Israel, RJ Hamilton, WB Livingston, PO
Citation: Pb. Chapman et al., Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine:A trial comparing doses of G(D2)-keyhole limpet hemocyanin, CLIN CANC R, 6(12), 2000, pp. 4658-4662
Paucity of functional T-cell memory to melanoma antigens in healthy donorsand melanoma patients
Authors: Dhodapkar, MV Young, JW Chapman, PB Cox, WI Fonteneau, JF Amigorena, S Houghton, AN Steinman, RM Bhardwaj, N
Citation: Mv. Dhodapkar et al., Paucity of functional T-cell memory to melanoma antigens in healthy donorsand melanoma patients, CLIN CANC R, 6(12), 2000, pp. 4831-4838
Systemic chemotherapy
Authors: Klimek, VM Wolchok, JD Chapman, PB Houghton, AN Hwu, WJ
Citation: Vm. Klimek et al., Systemic chemotherapy, CLIN PLAST, 27(3), 2000, pp. 451
Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide
Authors: Lewis, JJ Janetzki, S Schaed, S Panageas, KS Wang, SQ Williams, L Meyers, M Butterworth, L Livingston, PO Chapman, PB Houghton, AN
Citation: Jj. Lewis et al., Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide, INT J CANC, 87(3), 2000, pp. 391-398
Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy
Authors: Wolchok, JD Klimek, VM Williams, L Chapman, PB
Citation: Jd. Wolchok et al., Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy, CYTOK CELL, 5(4), 1999, pp. 205-206
Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells
Authors: Nasi, ML Lieberman, P Busam, KJ Prieto, V Panageas, KS Lewis, JJ Houghton, AN Chapman, PB
Citation: Ml. Nasi et al., Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells, CYTOK CELL, 5(3), 1999, pp. 139-144
Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guerin
Authors: Grant, SC Kris, MG Houghton, AN Chapman, PB
Citation: Sc. Grant et al., Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guerin, CLIN CANC R, 5(6), 1999, pp. 1319-1323
Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plusBCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies
Authors: Yao, TJ Meyers, M Livingston, PO Houghton, AN Chapman, PB
Citation: Tj. Yao et al., Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plusBCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies, CLIN CANC R, 5(1), 1999, pp. 77-81
Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma
Authors: Chapman, PB Einhorn, LH Meyers, ML Saxman, S Destro, AN Panageas, KS Begg, CB Agarwala, SS Schuchter, LM Ernstoff, MS Houghton, AN Kirkwood, JM
Citation: Pb. Chapman et al., Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma, J CL ONCOL, 17(9), 1999, pp. 2745-2751
The role of homophilic binding in anti-tumor antibody R24 recognition of molecular surfaces - Demonstration of an intermolecular beta-sheet interaction between V-H domains
Authors: Kaminski, MJ MacKenzie, CR Mooibroek, MJ Dahms, TES Hirama, T Houghton, AN Chapman, PB Evans, SV
Citation: Mj. Kaminski et al., The role of homophilic binding in anti-tumor antibody R24 recognition of molecular surfaces - Demonstration of an intermolecular beta-sheet interaction between V-H domains, J BIOL CHEM, 274(9), 1999, pp. 5597-5604
Risultati: 1-12 |